These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17960327)

  • 1. Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches.
    Katritch V; Byrd CM; Tseitin V; Dai D; Raush E; Totrov M; Abagyan R; Jordan R; Hruby DE
    J Comput Aided Mol Des; 2007; 21(10-11):549-58. PubMed ID: 17960327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an in vitro cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity.
    Byrd CM; Hruby DE
    Virol J; 2005 Aug; 2():63. PubMed ID: 16105175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dissection of the vaccinia virus I7L core protein proteinase.
    Byrd CM; Bolken TC; Hruby DE
    J Virol; 2003 Oct; 77(20):11279-83. PubMed ID: 14512576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vaccinia virus I7L gene product is the core protein proteinase.
    Byrd CM; Bolken TC; Hruby DE
    J Virol; 2002 Sep; 76(17):8973-6. PubMed ID: 12163618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases.
    Schulz R; Atef A; Becker D; Gottschalk F; Tauber C; Wagner S; Arkona C; Abdel-Hafez AA; Farag HH; Rademann J; Wolber G
    J Med Chem; 2018 Feb; 61(3):1218-1230. PubMed ID: 29328649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?
    Dodaro A; Pavan M; Moro S
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening.
    Xiong B; Gui CS; Xu XY; Luo C; Chen J; Luo HB; Chen LL; Li GW; Sun T; Yu CY; Yue LD; Duan WH; Shen JK; Qin L; Shi TL; Li YX; Chen KX; Luo XM; Shen X; Shen JH; Jiang HL
    Acta Pharmacol Sin; 2003 Jun; 24(6):497-504. PubMed ID: 12791174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.
    Huang L; Brinen LS; Ellman JA
    Bioorg Med Chem; 2003 Jan; 11(1):21-9. PubMed ID: 12467703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study.
    Berry M; Fielding BC; Gamieldien J
    Viruses; 2015 Dec; 7(12):6642-60. PubMed ID: 26694449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
    Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
    J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.
    Teixeira C; Gomes JR; Couesnon T; Gomes P
    J Comput Aided Mol Des; 2011 Aug; 25(8):763-75. PubMed ID: 21786172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov.
    Zhang H; Saravanan KM; Yang Y; Hossain MT; Li J; Ren X; Pan Y; Wei Y
    Interdiscip Sci; 2020 Sep; 12(3):368-376. PubMed ID: 32488835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
    Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R
    Science; 2003 Jun; 300(5626):1763-7. PubMed ID: 12746549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
    Goetz DH; Choe Y; Hansell E; Chen YT; McDowell M; Jonsson CB; Roush WR; McKerrow J; Craik CS
    Biochemistry; 2007 Jul; 46(30):8744-52. PubMed ID: 17605471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-covalent inhibitors of rhinovirus 3C protease.
    Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
    Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papain-like lysosomal cysteine proteases and their inhibitors: drug discovery targets?
    Turk D; Turk B; Turk V
    Biochem Soc Symp; 2003; (70):15-30. PubMed ID: 14587279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into Structures and Dynamics of Flavivirus Proteases from NMR Studies.
    Li Q; Kang C
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
    Lai L; Han X; Chen H; Wei P; Huang C; Liu S; Fan K; Zhou L; Liu Z; Pei J; Liu Y
    Curr Pharm Des; 2006; 12(35):4555-64. PubMed ID: 17168761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design.
    Toney JH; Navas-Martín S; Weiss SR; Koeller A
    J Med Chem; 2004 Feb; 47(5):1079-80. PubMed ID: 14971887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.